Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.
NCT01073839
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Cholangiocellular Carcinoma
Interventions
DRUG:
Cisplatin and Gemcitabine
Sponsor
University of Zurich